To combat the progression of fibrosis, exosomes from mesenchymal stem cells loaded with exogenous siRNA or antisense oligonucleotides (ASOs) against the transcription factor STAT3, a positive regulator of this disease, have been used in a mouse model of liver fibrosis. Here, STAT3 is linked to Hepatic fibrosis.